Digest Network Come funziona
Network
/
Società
F.
Non verificato

F. Hoffmann-La Roche Ltd

Di cosa scriviamo

Annunci EconomiciFarmaceuticaPubblicità/Marketing/Media/Comunicazione

102 comunicati stampa

Guarda tutti i comunicati
01/12/2025
Farmaceutica
Annunci Economici
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis)
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0
18/11/2025
Farmaceutica
Annunci Economici
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0
17/11/2025
Farmaceutica
Annunci Economici
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s giredestrant becomes the first oral SERD to show superior invasive disease-free survival in early breast cancer
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0
09/11/2025
Farmaceutica
Annunci Economici
Pubblicità/Marketing/Media/Comunicazione
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0
03/11/2025
Farmaceutica
Annunci Economici
Pubblicità/Marketing/Media/Comunicazione
Roche to present new data from its broad and innovative haematology portfolio at ASH 2025
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0
02/11/2025
Farmaceutica
Annunci Economici
Pubblicità/Marketing/Media/Comunicazione
Positive phase III data for Roche’s Gazyva/Gazyvaro show significant reduction in disease activity for systemic lupus erythematosus
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0
29/10/2025
Farmaceutica
Annunci Economici
Roche purchases shares in tender offer for 89bio, Inc
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0
28/10/2025
Farmaceutica
Annunci Economici
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0
27/10/2025
Farmaceutica
Annunci Economici
Pubblicità/Marketing/Media/Comunicazione
Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0
22/10/2025
Farmaceutica
Annunci Economici
Changes to the Roche Enlarged Corporate Executive Committee
Fonte
F. Hoffmann-La Roche Ltd
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0